Manufacturers Life Insurance Company, The Autolus Therapeutics PLC Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 28,333 shares of AUTL stock, worth $48,166. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,333
Previous 164,921
82.82%
Holding current value
$48,166
Previous $598,000
88.96%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AUTL
# of Institutions
112Shares Held
156MCall Options Held
0Put Options Held
116K-
Wellington Management Group LLP Boston, MA25.3MShares$43.1 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$34.8 Million0.24% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$28.3 Million73.83% of portfolio
-
Deep Track Capital, LP Greenwich, CT14.2MShares$24.2 Million1.47% of portfolio
-
Avoro Capital Advisors LLC New York, NY9.91MShares$16.8 Million0.34% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $155M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...